|
|
Data de intrare
|
| 4747 |
Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease. Pharmaceutics |
24/04/2023 |
| 4750 |
Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics |
24/04/2023 |
| 4744 |
Stability Report of Extended SB8 Opened Vial (400 mg) Stability. |
07/04/2023 |
| 4745 |
Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Pharmaceutical Technology in Hospital Pharmacy |
07/04/2023 |
| 4742 |
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel |
02/04/2023 |
| 4741 |
Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base,
SuspendIt. Int J Pharm Compound |
29/03/2023 |
| 4740 |
MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021 Roche Products Limited |
06/03/2023 |
| 4739 |
Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules. PlosOne |
04/03/2023 |
| 4736 |
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal |
20/02/2023 |
| 4735 |
Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags. J Oncol Pharm Practice |
08/02/2023 |
| 4732 |
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration. Am J Health-Syst Pharm |
02/02/2023 |
| 4729 |
Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with SterileWater for Ophthalmic Administration: Formulation and Stability Study. Pharmaceutics |
01/02/2023 |
| 4730 |
Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures. Neuromodulation |
01/02/2023 |
| 4728 |
Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies. J Pharm Biomed Anal |
22/01/2023 |
| 4727 |
Stability Study of Parenteral N-Acetylcysteine, and Chemical Inhibition of Its Dimerization Pharmaceuticals |
18/01/2023 |
| 4726 |
Arsenic trioxide Mylan - Résumé des caractéristiques du produit Mylan |
17/01/2023 |
| 4725 |
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers. J Pharm Biomed Anal |
10/01/2023 |
| 4723 |
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration. Am J Health-Syst Pharm |
21/12/2022 |
| 4724 |
Intravenous Physical Compatibility of Heparin Sodium and Furosemide. Int J Pharm Compound |
21/12/2022 |
| 4720 |
Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals |
20/11/2022 |
| 4717 |
Enhertu®- Résumé des caractéristiques du produit |
18/11/2022 |
| 4719 |
Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump. SAGE Open Medicine |
18/11/2022 |
| 4714 |
Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine. GERPAC Congrès - octobre 2022 |
03/11/2022 |
| 4716 |
Pre-formulation and Stability Study of 20 mcg Clonidine Hydrochloride Pediatric Capsules. J Pediatr Pharmacol Ther |
03/11/2022 |
| 4711 |
Physicochemical stability of subcutaneous daratumumab (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature. GERPAC Congrès - octobre 2022 |
27/10/2022 |
| 4712 |
Développement de formulations buvables de vinorelbine à usage pédiatrique. GERPAC Congrès - octobre 2022 |
27/10/2022 |
| 4710 |
Etude de stabilité physico-chimique du Cabazitaxel Zentiva® en flacons après "ouverture" et en solutions diluées en poches en perfusion de 3 types. GERPAC Congrès - octobre 2022 |
26/10/2022 |
| 4709 |
XERAVA® (eravacycline) for injection, for intravenous use. HIGHLIGHTS OF PRESCRIBING INFORMATION. Tetraphase Pharmaceuticals. |
11/10/2022 |
| 4708 |
Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage. Drugs R D |
15/09/2022 |
| 4705 |
Stability of voriconazole 10 mg/mL ophthalmic solution during 90 days Pharmaceutical Technology in Hospital Pharmacy |
12/09/2022 |
